Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases
Language English Country Germany Media print-electronic
Document type Journal Article
Grant support
R21 MH101673
NIMH NIH HHS - United States
R33 MH101673
NIMH NIH HHS - United States
PubMed
27775243
PubMed Central
PMC5198786
DOI
10.1002/cmdc.201600439
Knihovny.cz E-resources
- Keywords
- adenylate cyclase, anthrax, antibacterial agents, fluorescence, whooping cough,
- MeSH
- Adenylyl Cyclases metabolism MeSH
- Bordetella pertussis enzymology MeSH
- Fluorescent Dyes chemical synthesis chemistry pharmacology MeSH
- Adenylyl Cyclase Inhibitors chemical synthesis chemistry pharmacology MeSH
- Macrophages drug effects MeSH
- Molecular Structure MeSH
- Mice MeSH
- Nucleosides chemical synthesis chemistry pharmacology MeSH
- Organophosphonates chemical synthesis chemistry pharmacology MeSH
- Drug Design * MeSH
- Dose-Response Relationship, Drug MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Adenylyl Cyclases MeSH
- Fluorescent Dyes MeSH
- Adenylyl Cyclase Inhibitors MeSH
- Nucleosides MeSH
- Organophosphonates MeSH
Bordetella pertussis adenylate cyclase toxin (ACT) and Bacillus anthracis edema factor (EF) are key virulence factors with adenylate cyclase (AC) activity that substantially contribute to the pathogenesis of whooping cough and anthrax, respectively. There is an urgent need to develop potent and selective inhibitors of bacterial ACs with prospects for the development of potential antibacterial therapeutics and to study their molecular interactions with the target enzymes. Novel fluorescent 5-chloroanthraniloyl-substituted acyclic nucleoside phosphonates (Cl-ANT-ANPs) were designed and synthesized in the form of their diphosphates (Cl-ANT-ANPpp) as competitive ACT and EF inhibitors with sub-micromolar potency (IC50 values: 11-622 nm). Fluorescence experiments indicated that Cl-ANT-ANPpp analogues bind to the ACT active site, and docking studies suggested that the Cl-ANT group interacts with Phe306 and Leu60. Interestingly, the increase in direct fluorescence with Cl-ANT-ANPpp having an ester linker was strictly calmodulin (CaM)-dependent, whereas Cl-ANT-ANPpp analogues with an amide linker, upon binding to ACT, increased the fluorescence even in the absence of CaM. Such a dependence of binding on structural modification could be exploited in the future design of potent inhibitors of bacterial ACs. Furthermore, one Cl-ANT-ANP in the form of a bisamidate prodrug was able to inhibit B. pertussis ACT activity in macrophage cells with IC50 =12 μm.
See more in PubMed
Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA, Mooi FR. Plos Pathog. 2005;1:e45. PubMed PMC
Pertussis vaccines: WHO position paper: Weekly Epidemiological Record. 2010;85:385–400. PubMed
Kilgore PE, Salim AM, Zervos MJ, Schitt HJ. Clin. Microbiol. Rev. 2016;29:449–486. PubMed PMC
Tiwari T, Murphy TV, Moran J. [acccessed October 2015];Morbidity and Mortality Weekly Report. 2005 Dec 9; http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5414a1.htm. PubMed
Wood N, McIntyre P. Pediatr. Resp. Rev. 2008;9:201–212. PubMed
Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, Saubolle M, Lee B, Long J, Harrison AR, Jr, Besser JM. J. Clin. Microbiol. 2003;41:1167–1172. PubMed PMC
Wendelboe AM, Rie AV, Salmaso S, Englund JA. Pediatr. Infect. Dis. J. 2005;24:S58–S61. PubMed
Ladant D, Ullmann A. Trends Microbiol. 1999;7:172–176. PubMed
Confer DL, Eaton JW. Science. 1982;217:948–950. PubMed
Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A. EMBO J. 1988;7:3997–4004. PubMed PMC
Mock M, Ullmann A. Trends Microbiol. 1993;1:187–192. PubMed
Ahuja N, Kumar P, Bhatnagar R. Crit. Rev. Microbiol. 2004;30:187–196. PubMed
Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, Tang WJ. Proc. Natl. Acad. Sci. USA. 2004;101:3242–3247. PubMed PMC
Martín C, Gómez-Bilbao G, Ostolaza H. J.Biol. Chem. 2010;285:357–364. PubMed PMC
Fisher R, Masin J, Bumba L, Pospisilova E, Fayolle C, Basler M, Sadilkova L, Adkins I, Kamanova J, Cerny J, Konopasek I, Osicka R, Laclerc C, Sebo P. PLoS Pathog. 2012;8(4):e1002580. PubMed PMC
De Clercq A, Holý E, Rosenberg I, Sakuma T, Balzarini J, Maudgal PC. Nature. 1986;323:464–467. PubMed
De Clercq E, Holý A. Nat. Rev. Drug Discovery. 2005;4:928–940. PubMed
De Clercq E. Med. Res. Rev. 2013;33:1278–1303. PubMed
Reiser H, Wang J, Chong L, Watkins WJ, Ray AS, Shibata R, Birkus G, Cihlar T, Wu S, Li B, Liu X, Henne IN, Wolfgang GHI, Desai M, Rhodes GR, Fridland A, Lee WA, Plunkett W, Vail D, Thamm DH, Jeraj R, Tumas DB. Clin. Cancer Res. 2008;14:2824–2832. PubMed
Zídek Z, Potměšil P, Holý A. Toxicol. Appl. Pharmacol. 2003;192:246–253. PubMed
Keough DT, Hocková D, Rejman D, Špaček P, Vrbková S, Krečmerová M, Eng WS, Jans H, West NP, Naesens LM, de Jersey J, Guddat LW. J. Med. Chem. 2013;56:6967–6984. PubMed
Eng WS, Hocková D, Špaček P, Janeba Z, West NP, Woods K, Naesens LMJ, Keough DT, Guddat LW. J. Med. Chem. 2015;58:4822–4838. PubMed
Keough DT, Hocková D, Holý A, Naesens LM, Skinner-Adams TS, de Jersey J, Guddat LW. J. Med. Chem. 2009;52:4391–4399. PubMed
Hocková D, Keough DT, Janeba Z, Wang TH, de Jersey J, Guddat LW. J. Med. Chem. 2012;55:6209–6223. PubMed
Keough DT, Špaček P, Hocková D, Tichý T, Vrbková S, Slavětínská L, Janeba Z, Naesens L, Edstein MD, Chavchich M, Wang TH, de Jersey J, Guddat LW. J. Med. Chem. 2013;56:2513–2526. PubMed
Keough DT, Hocková D, Janeba Z, Wang T, Naesens L, Edstein MD, Chavchich M, Guddat LW. J. Med. Chem. 2015;58:827–846. PubMed
Kaiser MM, Hocková D, Wang T-H, Draèínský M, Poštová-Slavìtínská L, Procházková E, Edstein MD, Chavchich M, Keough DT, Guddat LW, Janeba Z. ChemMedChem. 2015;10:1707–1723. PubMed
Zídek Z, Franková D, Holý A. Antimicrob. Agents Chemother. 2001;45:3381–3386. PubMed PMC
Zídek Z, Franková D, Holý A. Int. J. Immunopharmacol. 2000;22:1121–1129. PubMed
Potměšil P, Krečmerová M, Kmoníčková E, Holý A, Zídek Z. Eur. J. Pharmacol. 2006;540:191–199. PubMed
Guo Q, Shen Y, Lee Y-S, Gibbs CS, Mrksich M, Tang W. EMBO J. 2005;24:3190–3201. PubMed PMC
Shen YQ, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, Tang WJ. Proc. Natl. Acad. Sci. USA. 2004;101:3242–3247. PubMed PMC
Shoshani I, Laux WHG, Périgaud Ch, Gosselin G, Johnson RA. J. Biol. Chem. 1999;274:34742–34744. PubMed
Česnek M, Jansa P, Šmídková M, Mertlíková-Kaiserová H, Dračínský M, Brust TF, Pávek P, Trejtnar F, Watts VJ, Janeba Z. ChemMedChem. 2015;10:1351–1364. PubMed
Šmídková M, Dvořáková A, Tloušťová E, Česnek M, Janeba Z, Mertlíková-Kaiserová H. Antimicrob. Agents Chemother. 2014;58:664–671. PubMed PMC
Pradere U, Garnier-Amblard EC, Coats SJ, Amblard F, Schinazi RF. Chem. Rev. 2014;114:9154–9218. PubMed PMC
Gille A, Seifert R. J. Biol. Chem. 2003;278:12672–12679. PubMed
Gille A, Lushington GH, Mou TC, Doughty MB, Johnson RA, Seifert R. J. Biol. Chem. 2004;279:19955–19969. PubMed
Seifert R, Dove S. Trends Microbiol. 2012;20:343–351. PubMed
Hiratsuka T. J. Biol. Chem. 1985;260:4784–4790. PubMed
Göttle M, Dove S, Steindel P, Shen Y, Tang W, Geduhn J, König B, Seifert R. Mol. Pharmacol. 2007;72:526–535. PubMed
Holý A. Collect. Czech. Chem. Commun. 1978;43:2054–2031.
Kuhn K, Owen DJ, Bader B, Wittinghofer A, Kuhlmann J, Waldmann H. J. Am. Chem. Soc. 2001;123:1023–1035. PubMed
Hradilová L, Poláková M, Dvořáková B, Hajdúch M, Petruš L. Carboh. Res. 2012;361:1–6. PubMed
Chen JJ, Cai X, Szostak JW. J. Am. Chem. Soc. 2009;131:2119–2121. PubMed PMC
Allison BD, Phuong VK, McAtee LC, et al. J. Med. Chem. 2006;49:6371–6390. PubMed
Twin H, Batey RA. Org. Lett. 2011;6:4913–4916. PubMed
Liu J, Deng X, Fitzgerald AE, Sales ZS, Vankatesan H, Mani S. Org. Biomol. Chem. 2011;9:2654–2660. PubMed
Krečmerová M, Masojídková M, Holý A. Collect. Czech. Chem. Commun. 2004;69:1889–1913.
Krečmerová M, Dračínský M, Hocková D, Holý A, Keough DT, Guddat LW. Bioorg. Med. Chem. 2012;20:1222–1230. PubMed
Vrbovská S, Holý A, Pohl R, Masojídková M. Collect. Czech. Chem. Commun. 2006;71:543–566.
Jansa P, Baszczynski O, Dračínský M, Votruba I, Zídek Z, Bahador G, Stepan G, Cihlar T, Mackman R, Holý A, Janeba Z. Eur. J. Med. Chem. 2011;46:3748–3754. PubMed
Holý A, Rosenberg I. Collect. Czech. Chem. Commun. 1987;52:2801–2809.
Moffatt JG, Khorana HG. J. Am. Chem. Soc. 1961;83:649–658.
Xu B, Stephens A, Kirschenheuter G, Greslin AF, Cheng X, Sennelo J, Cattaneo M, Zighetti ML, Chen A, Kim S, Kim HS, Bischofberger N, Cook G, Jacobson KA. J. Med. Chem. 2002;45:5694–5709. PubMed PMC
Kim HS, Barak D, Harden TK, Boyer JL, Jacobson KA. J. Med. Chem. 2001;44:3092–3108. PubMed PMC
Hackett M, Walker CB, Guo L, Gray MC, Van Cuyk S, Ullmann A, Shabonowith J, Hunt DF, Hewlett EL, Sebo P. J. Biol. Chem. 1995;270:20250–20253. PubMed
Iwaki M, Kamachi K, Konda T. Infect. Immun. 2000;68:3727–3730. PubMed PMC
Birkus G, Wang R, Liu X, Kutty N, MacArthur H, Cihlar T, Gibbs C, Swaminathan S, Lee W, McDemott M. Antimicrob. Agents Chemother. 2007;51:543–550. PubMed PMC
Luedtke CC, Andonian S, Igdoura S, Hermo L. J. Histochem. Cytochem. 2000;48:1131–1146. PubMed
Molecular Operating Environment (MOE) 2014:0901.
Chemical Computing Group Inc. 1010 Sherbooke St. West, Suite #910. Montreal, QC, Canada, H3A 2R7: 2016.
Šolínová V, Kaiser MM, Lukáč M, Janeba Z, Kašička V. J. Sep. Sci. 2014;37:295–303. PubMed
Conley JM, Brand CS, Bogard AS, Pratt EPS, Xu RQ, Hockerman GH, Ostrom RS, Dessauer CW, Watts VJ. J. Pharm. and Exp. Ther. 2013;347:276–287. PubMed PMC
Conley JM, Brust TF, Xu R, Burris KD, Watts VJ. J. Vis. Exp. 2014;83:e51218. PubMed PMC
Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects